Back to AL Alphabet Inc.
MAMagenta Therapeutics Inc
Showing 0 of 17 quarters
Position history for ALAlphabet Inc.'s holdings in Magenta Therapeutics Inc
As of its Q2 2023 13F, Alphabet held 3,339,138 shares of Magenta Therapeutics, worth $2.5M. Alphabet's 13F filings listed Magenta Therapeutics from Q3 2019 to Q2 2023, 16 quarterly filings. Magenta Therapeutics was 0.1% of Alphabet's reported 13F portfolio.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.